Boston Scientific announced its plan to acquire the company for $10 per share in November.
Apollo’s main focus is on the design, development and commercialization of less invasive gastrointestinal and endoscopic devices.
This acquisition will mark Boston Scientific’s entry into the endobariatric market, according to an April 4 news release shared with Becker’s.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.